Related Experiment Video
Updated: Jun 12, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Spinal cord sparing reirradiation with helical tomotherapy
Florian Sterzing1, Henrik Hauswald, Matthias Uhl
1Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany. florian.sterzing@med.uni-heidelberg.de
Cancer
|June 22, 2010
Summary
Helical tomotherapy enables spinal cord-sparing reirradiation for spinal tumors, providing significant pain relief and good local control with minimal toxicity. This advanced technique ensures precise dose delivery for improved patient outcomes.
Area of Science:
- Radiation Oncology
- Medical Physics
- Neurosurgery
Background:
- Spinal metastases and tumors often require reirradiation after initial radiotherapy.
- Previous radiotherapy can limit reirradiation options due to spinal cord tolerance.
- Helical tomotherapy offers a potential solution for precise, dose-escalated reirradiation while sparing critical structures.
Purpose of the Study:
- To evaluate the planning, feasibility, toxicity, and outcomes of helical tomotherapy for reirradiation of spinal metastases and tumors.
- To assess the effectiveness of spinal cord-sparing techniques in reirradiation scenarios.
- To determine the safety and efficacy of helical tomotherapy in managing recurrent or progressive spinal tumors.
Main Methods:
- Thirty-six patients with spinal metastases/tumors previously treated with radiotherapy underwent reirradiation using helical tomotherapy.
- The median time interval between previous radiotherapy and reirradiation was 17.5 months.
- Daily megavoltage computed tomography (CT) image guidance was utilized for precise dose application, with a median prescribed reirradiation dose of 34.8 Gy.
Main Results:
- Reirradiation achieved a median spinal cord dose of 9.8 Gy, significantly lower than the prior dose.
- A substantial reduction in pain was observed, with visual analogue scale scores decreasing from a median of 7 to 3 at 6 weeks post-therapy.
- One- and 2-year local control rates were 76% and 63%, respectively, with 1- and 2-year overall survival rates of 67% and 58%.
- Only one case of grade 2 skin toxicity was reported, with no higher-grade toxicities observed.
Conclusions:
- Helical tomotherapy facilitates effective reirradiation of spinal metastases, enabling excellent spinal cord sparing.
- The technique achieves significant pain relief and robust local tumor control.
- Precise dose delivery with steep dose gradients around previously irradiated tissues is possible using daily MVCT image guidance.
